GLA / Alpha-galactosidase A抗体

GLA / Alpha-galactosidase A抗体产品信息免疫原 : Recombinant Mouse GLA / Alpha-galactosidase A protein (Catalog#50964-M08H)

Antibody Type : Rabbit Polyclonal Antibody ( Antibody Purification Platform )
抗体宿主 : Rabbit IgG
缓冲液 : 0.2 μm filtered solution in PBS, 5% trehalose may be added in some batches. Please read the hardcopy of COA or contact our customer service to confirm the formulation.
制备方法 : Produced in rabbits immunized with purified, recombinant Mouse GLA / Alpha-galactosidase A (rM GLA / Alpha-galactosidase A; Catalog#50964-M08H; Q8BGZ6; Met1-Arg421). Total IgG was purified by Protein A affinity chromatography.
GLA / Alpha-galactosidase A抗体 Background
Alpha-galactosidase A, also known as Alpha-D-galactoside galactohydrolase, Alpha-D-galactosidase A, Melibiase and GLA, is a member of the glycosyl hydrolase 27 family. GLA is used as a long-term enzyme replacement therapy in patients with a confirmed diagnosis of Fabry disease. Defects in GLA are the cause of Fabry disease (FD) which is a rare X-linked sphingolipidosis disease where glycolipid accumulates in many tissues. The disease consists of an inborn error of glycosphingolipid catabolism. FD patients show systemic accumulation of globotriaoslyceramide (Gb3) and related glycosphingolipids in the plasma and cellular lysosomes throughout the body. Clinical recognition in males results from characteristic skin lesions (angiokeratomas) over the lower trunk. Patients may show ocular deposits, febrile episodes, and burning pain in the extremities. Death results from renal failure, cardiac or cerebral complications of hypertension or other vascular disease. Deficiency of GLA leads to the accumulation of glycosphingolipids in the vasculature leading to multiorgan pathology. In addition to well-described microvascular disease, deficiency of GLA is also characterized by premature macrovascular events such as stroke and possibly myocardial infarction.
GLA / Alpha-galactosidase A抗体相关产品如下：xy-9560R KRCC1含赖氨酸卷曲螺旋蛋白1抗体
xy-4812R Prostate Specific Antigen激肽释放酶3/舒血管素3抗体
xy-9526R KLF1, 2, 4上皮锌指蛋白1, 2, 4抗体
xy-1064R KLF4肠道内富含的Kruppel样因子/上皮锌指蛋白4抗体
xy-3549R KSR1Ras信号转导KSR1蛋白抗体
xy-0225M KLH血蓝蛋白抗体
xy-8546R KRIT1脑海绵状血管畸形蛋白1抗体
xy-9716R KBPKBP蛋白抗体
xy-1094R kappa Opioid receptorkappa型受体抗体
xy-7688R Kininogen-1 heavy chain激肽原1重链抗体
xy-7689R KCNMB1钙激活钾通道蛋白β1抗体
xy-9442R Kv4.2电压门控性钾通道蛋白Kv4.2抗体
xy-9443R phospho-Kv4.2(Thr602)磷酸化电压门控性钾通道蛋白Kv4.2抗体
xy-9444R phospho-Kv4.2(Thr607)磷酸化电压门控性钾通道蛋白Kv4.2抗体
xy-2112R KT3 tagKT3 tag抗体
xy-1963R KLK1激肽释放酶1抗体
xy-1964R KLK3激肽释放酶3/舒血管素3抗体
xy-1965R KLK4激肽释放酶4抗体
xy-9118R KMT1C组蛋白H3赖氨酸9甲基化1C抗体
xy-2494R Kif14 protein驱动蛋白家族Member14蛋白抗体
xy-2130R Ki-67Ki67蛋白抗体
xy-2424R KCNH1钾离子通道蛋白EAG1抗体
xy-1395R KLF6转染抑癌基因KLF6抗体
xy-3649R KLF8KLF样转录因子8抗体
xy-3648R KEAP1胞质接头蛋白Keap1抗体
xy-2303R phospho-KLF5(Ser311)磷酸化肠道内富含的Kruppel样因子5抗体
xy-10495R KMT6 (phospho Ser21)磷酸化抑癌蛋白EZH2抗体
xy-2231R LYRICAEG-1抗体
xy-6309R IL-6白介素6抗体
xy-2200R LDL低密度脂蛋白抗体
xy-12310R LRRC19LRRC19蛋白抗体
xym-4577M LAMR1(M1S3)层粘连蛋白受体1单克隆抗体
xym-0940M LAMR1(5D4)层粘连蛋白受体1单克隆抗体
xy-10126R LATT细胞活化连接蛋白抗体